GANX
Price
$3.22
Change
+$0.14 (+4.55%)
Updated
Dec 24 closing price
Capitalization
123.85M
84 days until earnings call
Intraday BUY SELL Signals
PYXS
Price
$1.11
Change
+$0.02 (+1.83%)
Updated
Dec 24 closing price
Capitalization
69.11M
90 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GANX vs PYXS

Header iconGANX vs PYXS Comparison
Open Charts GANX vs PYXSBanner chart's image
Gain Therapeutics
Price$3.22
Change+$0.14 (+4.55%)
Volume$793.24K
Capitalization123.85M
Pyxis Oncology
Price$1.11
Change+$0.02 (+1.83%)
Volume$1.42M
Capitalization69.11M
GANX vs PYXS Comparison Chart in %
GANX
Daily Signal:
Gain/Loss:
PYXS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GANX vs. PYXS commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GANX is a Buy and PYXS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 26, 2025
Stock price -- (GANX: $3.22 vs. PYXS: $1.11)
Brand notoriety: GANX and PYXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GANX: 51% vs. PYXS: 127%
Market capitalization -- GANX: $123.85M vs. PYXS: $69.11M
GANX [@Biotechnology] is valued at $123.85M. PYXS’s [@Biotechnology] market capitalization is $69.11M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GANX’s FA Score shows that 0 FA rating(s) are green whilePYXS’s FA Score has 1 green FA rating(s).

  • GANX’s FA Score: 0 green, 5 red.
  • PYXS’s FA Score: 1 green, 4 red.
According to our system of comparison, both GANX and PYXS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GANX’s TA Score shows that 6 TA indicator(s) are bullish while PYXS’s TA Score has 5 bullish TA indicator(s).

  • GANX’s TA Score: 6 bullish, 2 bearish.
  • PYXS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, GANX is a better buy in the short-term than PYXS.

Price Growth

GANX (@Biotechnology) experienced а -20.49% price change this week, while PYXS (@Biotechnology) price change was -67.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.88%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +55.39%.

Reported Earning Dates

GANX is expected to report earnings on Mar 19, 2026.

PYXS is expected to report earnings on Mar 25, 2026.

Industries' Descriptions

@Biotechnology (+2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GANX($124M) has a higher market cap than PYXS($69.1M). GANX YTD gains are higher at: 49.074 vs. PYXS (-28.846). GANX has higher annual earnings (EBITDA): -17.49M vs. PYXS (-83.07M). PYXS has more cash in the bank: 76.3M vs. GANX (8.81M). GANX has less debt than PYXS: GANX (605K) vs PYXS (19.1M). PYXS has higher revenues than GANX: PYXS (2.82M) vs GANX (0).
GANXPYXSGANX / PYXS
Capitalization124M69.1M179%
EBITDA-17.49M-83.07M21%
Gain YTD49.074-28.846-170%
P/E RatioN/AN/A-
Revenue02.82M-
Total Cash8.81M76.3M12%
Total Debt605K19.1M3%
TECHNICAL ANALYSIS
Technical Analysis
GANXPYXS
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend about 1 month ago
83%
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
GANX
Daily Signal:
Gain/Loss:
PYXS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BNDSF3.94N/A
N/A
Banco De Sabadell SA
AUCTF8.96N/A
N/A
AUCNET INC.
AABVF0.02N/A
N/A
Aberdeen International Inc.
KELRF7.85N/A
N/A
Keisei Electric Rail
RMHI2.07N/A
N/A
Retrieve Medical Holdings Inc

GANX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GANX has been loosely correlated with HOWL. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if GANX jumps, then HOWL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GANX
1D Price
Change %
GANX100%
+4.55%
HOWL - GANX
46%
Loosely correlated
+5.04%
COYA - GANX
39%
Loosely correlated
+2.97%
PYXS - GANX
38%
Loosely correlated
+1.83%
AXON - GANX
36%
Loosely correlated
+0.02%
CRNX - GANX
35%
Loosely correlated
-0.33%
More

PYXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PYXS has been loosely correlated with HOWL. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if PYXS jumps, then HOWL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYXS
1D Price
Change %
PYXS100%
+1.83%
HOWL - PYXS
44%
Loosely correlated
+5.04%
IPSC - PYXS
39%
Loosely correlated
+6.19%
GANX - PYXS
38%
Loosely correlated
+4.55%
DAWN - PYXS
37%
Loosely correlated
-0.31%
BEAM - PYXS
37%
Loosely correlated
+1.33%
More